ABAsmaa Badr

Asmaa Badr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Asmaa Badr has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Amy Webb

    Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA

    2 shared publications
  • Gauruv Gupta

    Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA

    2 shared publications
  • Heba M. Amer

    Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA

    2 shared publications
  • Owen Whitham

    Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA

    2 shared publications
  • Xiaoli Zhang

    College of Nursing, University of South Florida, Tampa, Florida, USA

    2 shared publications
  • Amal O. Amer

    Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA

    1 shared publication

Latest Publications

  • Open Access

    AI-based decoding of long covid cognitive impairments in mice using automated behavioral system and comparative transcriptomic analysis

    by Heba M. Amer, Mohamed M. Shamseldin, Sarah Faber, Mostafa Eltobgy, Amy Webb, Rabab El-Mergawy, Michelle Chamblee, Richard Perez, Owen Whitham, Asmaa Badr, et al.

    Long COVID (LC) following SARS-CoV-2 infection affects millions of individuals world-wide and manifests with a variety of symptoms including cognitive dysfunction also known as “brain fog”. This is characterized by difficulties in executive functions, planning, decision-making, working memory, impairments in complex attention, loss of ability to learn new skills and perform sophisticated brain tasks. No effective treatment options currently exist for LC-related cognitive dysfunction. Here, we use the IntelliCage, which is an automated tracking system of cognitive functions, following SARS-CoV-2 infection in mice, measuring the ability of each mouse within a group to perform tasks that mimic complex human behaviors, such as planning, decision-making, cognitive flexibility, and working memory. Artificial intelligence and machine learning analyses of the tracking data classified LC mice into distinct behavioral categories from non-infected control mice, permitting precise identification and quantification of complex cognitive dysfunction in a controlled, replicable manner. Importantly, we find that brains from LC mice with cognitive dysfunction exhibit transcriptomic alterations similar to those observed in humans suffering from LC-related cognitive impairments, including altered expression of genes involved in learning, executive functions, synaptic functions, neurotransmitters and memory. Together, our findings establish a validated murine model and an automated unbiased approach to study LC-related cognitive dysfunction for the first time, and providing a valuable tool for screening potential treatments and therapeutic interventions.

  • Open Access

    Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer’s disease

    by Asmaa Badr, Kylene P. Daily, Mostafa Eltobgy, Shady Estfanous, Michelle H. Tan, Jimmy Chun-Tien Kuo, Owen Whitham, Cierra Carafice, Gauruv Gupta, Heba M. Amer, et al.